Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Lutz, Frölich"'
Autor:
Mathieu Ceccaldi, Timo Grimmer, Vesna Jelic, Luiza Spiru, Pierre Jean Ousset, Stephanie Sloan, Marcel G. M. Olde Rikkert, Isabel Santana, Sebastiaan Engelborghs, Bruno Dubois, Milica G. Kramberger, David Robinson, Lucrezia Hausner, Latchezar Traykov, Mercè Boada, Robert Perneczky, Gunhild Waldemar, Alberto Lleó, Elisabet Sánchez, Thomas R. Nielsen, Tomasz Gabryelewicz, Olivier Rouaud, Nikolaos Scarmeas, Alexandre de Mendonça, Jacques Hugon, Kristian Steen Frederiksen, Bernard Hanseeuw, Lutz Frölich, Flavio Nobili, Görsev Yener, Mario Riverol, Ildebrando Appollonio, Audrey Gabelle, Birgitte Bo Andersen, Elka Stefanova, Katerina Sheardova, Jakub Hort, Anne M Koivisto, Thibaud Lebouvier
Publikováno v:
International Journal of Geriatric Psychiatry, 36, 2, pp. 324-333
International journal of geriatric psychiatry: a journal of the psychiatry of late life and allied sciences
International Journal of Geriatric Psychiatry, 36, 324-333
International Journal of Geriatric Psychiatry, Vol. 36, no. 2, p. 324-333 (2021)
Frederiksen, K S, Nielsen, T R, Appollonio, I, Andersen, B B, Riverol, M, Boada, M, Ceccaldi, M, Dubois, B, Engelborghs, S, Frölich, L, Hausner, L, Gabelle, A, Gabryelewicz, T, Grimmer, T, Hanseeuw, B, Hort, J, Hugon, J, Jelic, V, Koivisto, A, Kramberger, M G, Lebouvier, T, Lleó, A, de Mendonça, A, Nobili, F, Ousset, P J, Perneczky, R, Olde Rikkert, M, Robinson, D, Rouaud, O, Sánchez, E, Santana, I, Scarmeas, N, Sheardova, K, Sloan, S, Spiru, L, Stefanova, E, Traykov, L, Yener, G & Waldemar, G 2021, ' Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment : A European Alzheimer's disease consortium survey ', International Journal of Geriatric Psychiatry, vol. 36, no. 2, pp. 324-333 . https://doi.org/10.1002/gps.5427
International journal of geriatric psychiatry 36(2), 324-333 (2021). doi:10.1002/gps.5427
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
International Journal of Geriatric Psychiatry
International Journal of Geriatric Psychiatry, 2021, 36 (2), pp.324-333. ⟨10.1002/gps.5427⟩
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
International journal of geriatric psychiatry: a journal of the psychiatry of late life and allied sciences
International Journal of Geriatric Psychiatry, 36, 324-333
International Journal of Geriatric Psychiatry, Vol. 36, no. 2, p. 324-333 (2021)
Frederiksen, K S, Nielsen, T R, Appollonio, I, Andersen, B B, Riverol, M, Boada, M, Ceccaldi, M, Dubois, B, Engelborghs, S, Frölich, L, Hausner, L, Gabelle, A, Gabryelewicz, T, Grimmer, T, Hanseeuw, B, Hort, J, Hugon, J, Jelic, V, Koivisto, A, Kramberger, M G, Lebouvier, T, Lleó, A, de Mendonça, A, Nobili, F, Ousset, P J, Perneczky, R, Olde Rikkert, M, Robinson, D, Rouaud, O, Sánchez, E, Santana, I, Scarmeas, N, Sheardova, K, Sloan, S, Spiru, L, Stefanova, E, Traykov, L, Yener, G & Waldemar, G 2021, ' Biomarker counseling, disclosure of diagnosis and follow-up in patients with mild cognitive impairment : A European Alzheimer's disease consortium survey ', International Journal of Geriatric Psychiatry, vol. 36, no. 2, pp. 324-333 . https://doi.org/10.1002/gps.5427
International journal of geriatric psychiatry 36(2), 324-333 (2021). doi:10.1002/gps.5427
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
International Journal of Geriatric Psychiatry
International Journal of Geriatric Psychiatry, 2021, 36 (2), pp.324-333. ⟨10.1002/gps.5427⟩
r-IIB SANT PAU: Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)
Contains fulltext : 231797.pdf (Publisher’s version ) (Closed access) OBJECTIVES: Mild cognitive impairment (MCI) is associated with an increased risk of further cognitive decline, partly depending on demographics and biomarker status. The aim of t
Autor:
Isabelle Bos, Henrik Zetterberg, Daniel Alcolea, Gwendoline Peyratout, B. Paul Morgan, Susan Baker, Simon Lovestone, Liu Shi, Fabian Kilpert, Lars Bertram, Shengjun Hong, Ellen Elisa De Roeck, Alberto Lleó, Mikel Tainta, Pablo Martinez-Lage, Kaj Blennow, Alison L. Baird, Olivier Blin, Lorena Rami, José Luis Molinuevo, Kristel Sleegers, Yvonne Freund-Levi, Lutz Frölich, Angharad R. Morgan, Pieter Jelle Visser, Rik Vandenberghe, Philip Scheltens, Silvy Gabel, Charlotte E. Teunissen, Petronella Kettunen, Julius Popp, Jill C. Richardson, Noel J. Buckley, Stephanie J. B. Vos, Abdul Hye, Johannes Streffer, Sarah Westwood, Nicholas J. Ashton, Valerija Dobricic, Alejo J. Nevado-Holgado, Magda Tsolaki, Giovanni B. Frisoni, Andre Franke, Frans R.J. Verhey, Sebastiaan Engelborghs, Mara ten Kate, Régis Bordet, Cristina Legido-Quigley, Laura Winchester, Anders Wallin, Karen Meersmans, Frederik Barkhof, Peter Johannsen
Publikováno v:
Alzheimer's & Dementia, Vol. 15, No 11 (2019) pp. 1478-1488
Alzheimer's & Dementia
Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2019, 15 (11), pp.1478-1488. ⟨10.1016/j.jalz.2019.06.4951⟩
Alzheimer's & dementia
Alzheimer's and Dementia, 15(11), 1478-1488. Elsevier
Alzheimers & Dementia
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Shi, L, Westwood, S, Baird, A L, Winchester, L, Dobricic, V, Kilpert, F, Hong, S, Franke, A, Hye, A, Ashton, N J, Morgan, A R, Bos, I, Vos, S J B, Buckley, N J, Kate, M T, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, de Roeck, E E, Sleegers, K, Frisoni, G B, Blin, O, Richardson, J C, Bordet, R G, Molinuevo, J L, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Teunissen, C E, Freund-Levi, Y, Frölich, L, Legido-Quigley, C, Barkhof, F, Blennow, K, Zetterberg, H, Baker, S, Morgan, B P, Streffer, J, Visser, P J, Bertram, L, Lovestone, S & Nevado-Holgado, A J 2019, ' Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay ', Alzheimer's and Dementia, vol. 15, no. 11, pp. 1478-1488 . https://doi.org/10.1016/j.jalz.2019.06.4951
Alzheimer's & dementia, vol. 15, no. 11, pp. 1478-1488
Alzheimer's & Dementia, 15(11), 1478-1488. Elsevier Science
Alzheimer's & Dementia
Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2019, 15 (11), pp.1478-1488. ⟨10.1016/j.jalz.2019.06.4951⟩
Alzheimer's & dementia
Alzheimer's and Dementia, 15(11), 1478-1488. Elsevier
Alzheimers & Dementia
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Shi, L, Westwood, S, Baird, A L, Winchester, L, Dobricic, V, Kilpert, F, Hong, S, Franke, A, Hye, A, Ashton, N J, Morgan, A R, Bos, I, Vos, S J B, Buckley, N J, Kate, M T, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, de Roeck, E E, Sleegers, K, Frisoni, G B, Blin, O, Richardson, J C, Bordet, R G, Molinuevo, J L, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Teunissen, C E, Freund-Levi, Y, Frölich, L, Legido-Quigley, C, Barkhof, F, Blennow, K, Zetterberg, H, Baker, S, Morgan, B P, Streffer, J, Visser, P J, Bertram, L, Lovestone, S & Nevado-Holgado, A J 2019, ' Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay ', Alzheimer's and Dementia, vol. 15, no. 11, pp. 1478-1488 . https://doi.org/10.1016/j.jalz.2019.06.4951
Alzheimer's & dementia, vol. 15, no. 11, pp. 1478-1488
Alzheimer's & Dementia, 15(11), 1478-1488. Elsevier Science
Plasma proteins have been widely studied as candidate biomarkers to predict brain amyloid deposition to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. Most such biomarker studies are targeted to speci
Autor:
Alireza Atri, Neli Boneva, José Luis Molinuevo, Lutz Frölich, Clive Ballard, Jeffrey L. Cummings, Pierre N. Tariot, Lars Lau Raket
Publikováno v:
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction Heterogeneity of outcomes in Alzheimer's disease (AD) clinical trials necessitates large sample sizes and contributes to study failures. This analysis determined whether mild-to-moderate AD populations could be enriched for cognitive dec
Autor:
Giovanni B. Frisoni, Chris Cooper, Bengt Winblad, Elka Stefanova, L. Mantoan Ritter, Jean Georges, P. Passmore, Lutz Frölich, Ana Verdelho, R. Schmidt, Kristian Steen Frederiksen, Mathieu Vandenbulcke, Dorota Religa, Milica G. Kramberger, Gunhild Waldemar, C. Nilsson
Publikováno v:
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
European Journal of Neurology
Frederiksen, K S, Cooper, C, Frisoni, G B, Frölich, L, Georges, J, Kramberger, M G, Nilsson, C, Passmore, P, Mantoan Ritter, L, Religa, D, Schmidt, R, Stefanova, E, Verdelho, A, Vandenbulcke, M, Winblad, B & Waldemar, G 2020, ' A European Academy of Neurology guideline on medical management issues in dementia ', European Journal of Neurology, vol. 27, no. 10, pp. 1805-1820 . https://doi.org/10.1111/ene.14412
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
European Journal of Neurology
Frederiksen, K S, Cooper, C, Frisoni, G B, Frölich, L, Georges, J, Kramberger, M G, Nilsson, C, Passmore, P, Mantoan Ritter, L, Religa, D, Schmidt, R, Stefanova, E, Verdelho, A, Vandenbulcke, M, Winblad, B & Waldemar, G 2020, ' A European Academy of Neurology guideline on medical management issues in dementia ', European Journal of Neurology, vol. 27, no. 10, pp. 1805-1820 . https://doi.org/10.1111/ene.14412
© 2020 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
Background and purpose: Dementia is one of the most common disorders and is associated with increased morbidity, mo
Background and purpose: Dementia is one of the most common disorders and is associated with increased morbidity, mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7caacfc7e39cc909f5894081e52a502f
https://lirias.kuleuven.be/handle/20.500.12942/703881
https://lirias.kuleuven.be/handle/20.500.12942/703881
Autor:
Frank Jessen, Andreas Fellgiebel, Klaus Fliessbach, Annika Spottke, Christine A. F. von Arnim, Tanja Richter-Schmidinger, Arne Klostermann, Jens Wiltfang, Richard Dodel, Lucrezia Hausner, Katharina Buerger, Stefan Klöppel, Franziska Maier, Martin Hellmich, Johannes Kornhuber, Josef Priller, Stefan J. Teipel, Jan-Philipp Bach, Christoph Laske, Lutz Frölich, Kija Shah-Hosseini, Claudia Bartels, Oliver Peters, Anja Schneider
Publikováno v:
JAMA Network Open
JAMA network open 3(5), e206027-(2020). doi:10.1001/jamanetworkopen.2020.6027
Maier, Franziska; Spottke, Annika; Bach, Jan-Philipp; Bartels, Claudia; Buerger, Katharina; Dodel, Richard; Fellgiebel, Andreas; Fliessbach, Klaus; Frölich, Lutz; Hausner, Lucrezia; Hellmich, Martin; Klöppel, Stefan; Klostermann, Arne; Kornhuber, Johannes; Laske, Christoph; Peters, Oliver; Priller, Josef; Richter-Schmidinger, Tanja; Schneider, Anja; Shah-Hosseini, Kija; ... (2020). Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial. JAMA Network Open, 3(5), e206027. American Medical Association 10.1001/jamanetworkopen.2020.6027
JAMA network open 3(5), e206027-(2020). doi:10.1001/jamanetworkopen.2020.6027
Maier, Franziska; Spottke, Annika; Bach, Jan-Philipp; Bartels, Claudia; Buerger, Katharina; Dodel, Richard; Fellgiebel, Andreas; Fliessbach, Klaus; Frölich, Lutz; Hausner, Lucrezia; Hellmich, Martin; Klöppel, Stefan; Klostermann, Arne; Kornhuber, Johannes; Laske, Christoph; Peters, Oliver; Priller, Josef; Richter-Schmidinger, Tanja; Schneider, Anja; Shah-Hosseini, Kija; ... (2020). Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial. JAMA Network Open, 3(5), e206027. American Medical Association 10.1001/jamanetworkopen.2020.6027
Key Points Question Is bupropion an effective and safe treatment for apathy in nondepressed patients with dementia of Alzheimer type? Findings In this 12-week, multicenter, double-blind, placebo-controlled, randomized clinical trial, 54 patients rece
Autor:
Mercè Boada, Alfredo Ramirez, Itziar de Rojas, Isabel Hernández, Silvia Gil, Alfredo Cabrera-Socorro, Isabelle Kohler, Agustín Ruiz, Thomas Hankemeier, Cornelia M. van Duijn, Najaf Amin, Margot H.M. Bakker, Lutz Frölich, Adelina Orellana, Lucrezia Hausner, Shahzad Ahmad
Publikováno v:
Alzheimer's Research & Therapy
Alzheimers Research & Therapy, 12(1):124. BioMed Central Ltd.
Alzheimer's Research & Therapy, 12(1):124. BioMed Central
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2020)
Alzheimer’s Research & Therapy, 12, 124. BMC
Ahmad, S, Orellana, A, Kohler, I, Frölich, L, de Rojas, I, Gil, S, Boada, M, Hernández, I, Hausner, L, Bakker, M H M, Cabrera-Socorro, A, Amin, N, Ramírez, A, Ruiz, A, Hankemeier, T & Van Duijn, C M 2020, ' Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer's disease ', Alzheimer's Research & Therapy, vol. 12, no. 1, 124, pp. 124 . https://doi.org/10.1186/s13195-020-00680-9
Alzheimers Research & Therapy, 12(1):124. BioMed Central Ltd.
Alzheimer's Research & Therapy, 12(1):124. BioMed Central
Alzheimer’s Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2020)
Alzheimer’s Research & Therapy, 12, 124. BMC
Ahmad, S, Orellana, A, Kohler, I, Frölich, L, de Rojas, I, Gil, S, Boada, M, Hernández, I, Hausner, L, Bakker, M H M, Cabrera-Socorro, A, Amin, N, Ramírez, A, Ruiz, A, Hankemeier, T & Van Duijn, C M 2020, ' Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer's disease ', Alzheimer's Research & Therapy, vol. 12, no. 1, 124, pp. 124 . https://doi.org/10.1186/s13195-020-00680-9
Background Lysophosphatidic acids (LPAs) are bioactive signaling phospholipids that have been implicated in Alzheimer’s disease (AD). It is largely unknown whether LPAs are associated with AD pathology and progression from mild cognitive impairment
Autor:
Simon Lovestone, Lars Bertram, Ruth Frikke-Schmidt, Patrizia Mecocci, Jill C. Richardson, Giovanni B. Frisoni, Fabian Kilpert, B. Paul Morgan, Abdul Hye, Stephanie J.B. Vos, Olivier Blin, Valerija Dobricic, Silvy Gabel, Richard Dobson, Mikel Tainta, Shengjun Hong, Frederik Barkhof, Cristina Legido-Quigley, Frans R.J. Verhey, Liu Shi, Børge G. Nordestgaard, Katrine L. Rasmussen, Pablo Martinez-Lage, Alejo J. Nevado-Holgado, Steven J. Kiddle, Charlotte E. Teunissen, Iwona Kłoszewska, Nicholas J. Ashton, Sebastiaan Engelborghs, Noel J. Buckley, Antonio Cuadrado, Petronella Kettunen, Bruno Vellas, José Luis Molinuevo, Kristel Sleegers, Alison L. Baird, Isabelle Bos, Angharad R. Morgan, Pieter Jelle Visser, Martina Sattlecker, Benjamine Y Liu, Mara ten Kate, Daniel Alcolea, Alberto Lleó, Ellen Elisa De Roeck, Lorena Rami, Elena M. Ribe, Andre Franke, Rik Vandenberghe, Julius Popp, Sarah Westwood, Régis Bordet, Magda Tsolaki, Yvonne Freund-Levi, Kaj Blennow, Philip Scheltens, Sune F. Nielsen, Gwendoline Peyratout, Peter Johannsen, Henrik Zetterberg, Hilkka Soininen, Johannes Streffer, Lutz Frölich, Karen Meersmans, Laura Winchester, Anders Wallin, Richard Killick
Publikováno v:
Shi, L, Winchester, L M, Liu, B Y, Killick, R, Ribe, E M, Westwood, S, Baird, A L, Buckley, N J, Hong, S, Dobricic, V, Kilpert, F, Franke, A, Kiddle, S, Sattlecker, M, Dobson, R, Cuadrado, A, Hye, A, Ashton, N J, Morgan, A R, Bos, I, Vos, S J B, Ten Kate, M, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, E E, Sleegers, K, Frisoni, G B, Blin, O, Richardson, J C, Bordet, R, Molinuevo, J L, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Teunissen, C E, Freund-Levi, Y, Frölich, L, Legido-Quigley, C, Barkhof, F, Blennow, K, Rasmussen, K L, Nordestgaard, B G, Frikke-Schmidt, R, Nielsen, S F, Soininen, H, Vellas, B, Kloszewska, I, Mecocci, P, Zetterberg, H, Morgan, B P, Streffer, J, Visser, P J, Bertram, L, Nevado-Holgado, A J & Lovestone, S 2020, ' Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology ', Journal of Alzheimer's Disease, vol. 77, no. 3, pp. 1353-1368 . https://doi.org/10.3233/JAD-200208
Journal of Alzheimer's Disease
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Alzheimer's Disease, 77(3), 1353-1368. IOS Press
Shi, L, Winchester, L M, Liu, B Y, Killick, R, Ribe, E M, Westwood, S, Baird, A L, Buckley, N J, Hong, S, Dobricic, V, Kilpert, F, Franke, A, Kiddle, S, Sattlecker, M, Dobson, R, Cuadrado, A, Hye, A, Ashton, N J, Morgan, A R, Bos, I, Vos, S J B, ten Kate, M, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, de Roeck, E E, Sleegers, K, Frisoni, G B, Blin, O, Richardson, J C, Bordet, R G, Molinuevo, J L, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Teunissen, C E, Freund-Levi, Y, Frölich, L, Legido-Quigley, C, Barkhof, F, Blennow, K, Rasmussen, K L, Nordestgaard, B R G, Frikke-Schmidt, R, Nielsen, S F, Soininen, H, Vellas, B, Kloszewska, I, Mecocci, P, Zetterberg, H, Morgan, B P, Streffer, J, Visser, P J, Bertram, L, Nevado-Holgado, A J & Lovestone, S 2020, ' Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology ', Journal of Alzheimer's Disease, vol. 77, no. 3, pp. 1353-1368 . https://doi.org/10.3233/JAD-200208
Journal of Alzheimer's disease
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of Alzheimer's Disease, IOS Press, 2020, 77 (3), pp.1353-1368. ⟨10.3233/JAD-200208⟩
JOURNAL OF ALZHEIMERS DISEASE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Journal of Alzheimer's disease, vol. 77, no. 3, pp. 1353-1368
Journal of Alzheimer's Disease
Dipòsit Digital de Documents de la UAB
Universitat Autònoma de Barcelona
Journal of Alzheimer's Disease, 77(3), 1353-1368. IOS Press
Shi, L, Winchester, L M, Liu, B Y, Killick, R, Ribe, E M, Westwood, S, Baird, A L, Buckley, N J, Hong, S, Dobricic, V, Kilpert, F, Franke, A, Kiddle, S, Sattlecker, M, Dobson, R, Cuadrado, A, Hye, A, Ashton, N J, Morgan, A R, Bos, I, Vos, S J B, ten Kate, M, Scheltens, P, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, de Roeck, E E, Sleegers, K, Frisoni, G B, Blin, O, Richardson, J C, Bordet, R G, Molinuevo, J L, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lleó, A, Alcolea, D, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Teunissen, C E, Freund-Levi, Y, Frölich, L, Legido-Quigley, C, Barkhof, F, Blennow, K, Rasmussen, K L, Nordestgaard, B R G, Frikke-Schmidt, R, Nielsen, S F, Soininen, H, Vellas, B, Kloszewska, I, Mecocci, P, Zetterberg, H, Morgan, B P, Streffer, J, Visser, P J, Bertram, L, Nevado-Holgado, A J & Lovestone, S 2020, ' Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology ', Journal of Alzheimer's Disease, vol. 77, no. 3, pp. 1353-1368 . https://doi.org/10.3233/JAD-200208
Journal of Alzheimer's disease
Digital.CSIC. Repositorio Institucional del CSIC
instname
Journal of Alzheimer's Disease, IOS Press, 2020, 77 (3), pp.1353-1368. ⟨10.3233/JAD-200208⟩
JOURNAL OF ALZHEIMERS DISEASE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Journal of Alzheimer's disease, vol. 77, no. 3, pp. 1353-1368
© 2020 – IOS Press and the authors.
[Background]: Previous studies suggest that Dickkopf-1 (DKK1), an inhibitor of Wnt signaling, plays a role in amyloid-induced toxicity and hence Alzheimer’s disease (AD). However, the effect of DKK1 expre
[Background]: Previous studies suggest that Dickkopf-1 (DKK1), an inhibitor of Wnt signaling, plays a role in amyloid-induced toxicity and hence Alzheimer’s disease (AD). However, the effect of DKK1 expre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece2f91b560d753f2bdb4e65d088a1d5
https://curis.ku.dk/ws/files/255888917/jad_2020_77_3_jad_77_3_jad200208_jad_77_jad200208.pdf
https://curis.ku.dk/ws/files/255888917/jad_2020_77_3_jad_77_3_jad200208_jad_77_jad200208.pdf
Autor:
Bruno Dubois, Gunhild Waldemar, Lutz Frölich, Reinhold Schmidt, Timo Grimmer, Sebastiaan Engelborghs, Roy W. Jones, Jean Georges, Milica G. Kramberger, Kristian Steen Frederiksen, T. Rune Nielsen, Bengt Winblad, Jakub Hort
Publikováno v:
European Journal of Neurology
European Journal of Neurology, Wiley, 2020, 28 (7), pp.2147-2155. ⟨10.1111/ene.14668⟩
Frederiksen, K S, Nielsen, T R, Winblad, B, Schmidt, R, Kramberger, M G, Jones, R W, Hort, J, Grimmer, T, Georges, J, Frölich, L, Engelborghs, S, Dubois, B & Waldemar, G 2021, ' European Academy of Neurology/European Alzheimer’s Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment ', European Journal of Neurology, vol. 28, no. 7, pp. 2147-2155 . https://doi.org/10.1111/ene.14668
European journal of neurology
European Journal of Neurology, Wiley, 2020, 28 (7), pp.2147-2155. ⟨10.1111/ene.14668⟩
Frederiksen, K S, Nielsen, T R, Winblad, B, Schmidt, R, Kramberger, M G, Jones, R W, Hort, J, Grimmer, T, Georges, J, Frölich, L, Engelborghs, S, Dubois, B & Waldemar, G 2021, ' European Academy of Neurology/European Alzheimer’s Disease Consortium position statement on diagnostic disclosure, biomarker counseling, and management of patients with mild cognitive impairment ', European Journal of Neurology, vol. 28, no. 7, pp. 2147-2155 . https://doi.org/10.1111/ene.14668
European journal of neurology
International audience; Background and purpose: Careful counseling through the diagnostic process and adequate postdiagnostic support in patients with mild cognitive impairment (MCI) is important. Previous studies have indicated heterogeneity in prac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e055fa87eadd34577df106f27027105c
https://hal.sorbonne-universite.fr/hal-03346174/file/ene.14668.pdf
https://hal.sorbonne-universite.fr/hal-03346174/file/ene.14668.pdf
Autor:
Isabelle Bos, Gwendoline Peyratout, Yvonne Freund-Levi, Ellen Elisa De Roeck, Mara ten Kate, Kristel Sleegers, Susan Baker, Mikel Tainta, Lutz Frölich, Giovanni B. Frisoni, Cristina Legido-Quigley, Karen Meersmans, Andrey Kormilitzin, Abdul Hye, Valerija Dobricic, Alison L. Baird, Alberto Lleó, Régis Bordet, Johannes Streffer, Isabel Sala, Sneha N Anand, Lorena Rami, B. Paul Morgan, Silvy Gabel, Julius Popp, Noel J. Buckley, Olivier Blin, José Luis Molinuevo, Sarah Westwood, Angharad R. Morgan, Frans R.J. Verhey, Pieter Jelle Visser, Magda Tsolaki, Martinez-Lage P, Rik Vandenberghe, Alejo J. Nevado-Holgado, Simon Lovestone, Lars Bertram, Henrik Zetterberg, Anders Wallin, Philip Scheltens, Peter Johannsen, Nicholas J. Ashton, Charlotte E. Teunissen, Petronella Kettunen, Sebastiaan Engelborghs, Stephanie J.B. Vos, Frederik Barkhof, Liu Shi, Jill C. Richardson
Publikováno v:
Westwood, S, Baird, A L, Anand, S N, Nevado-Holgado, A J, Kormilitzin, A, Shi, L, Hye, A, Ashton, N J, Morgan, A R, Bos, I, Vos, S J B, Baker, S, Buckley, N J, Ten Kate, M, Scheltens, P, Teunissen, C E, Vandenberghe, R, Gabel, S, Meersmans, K, Engelborghs, S, De Roeck, E E, Sleegers, K, Frisoni, G B, Blin, O, Richardson, J C, Bordet, R, Molinuevo, J L, Rami, L, Wallin, A, Kettunen, P, Tsolaki, M, Verhey, F, Lléo, A, Sala, I, Popp, J, Peyratout, G, Martinez-Lage, P, Tainta, M, Johannsen, P, Freund-Levi, Y, Frölich, L, Dobricic, V, Legido-Quigley, C, Bertram, L, Barkhof, F, Zetterberg, H, Morgan, B P, Streffer, J, Visser, P J & Lovestone, S 2020, ' Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort ', Journal of Alzheimer's Disease, vol. 74, no. 1, pp. 213-225 . https://doi.org/10.3233/JAD-190434
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease, 2020, 74 (1), pp.213-225. ⟨10.3233/JAD-190434⟩
JOURNAL OF ALZHEIMERS DISEASE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Alzheimer's Disease, 74(1), 213-225. IOS Press
Journal of Alzheimer's disease, vol. 74, no. 1, pp. 213-225
Journal of Alzheimer's disease
Journal of Alzheimer's Disease, Vol. 74, No 1 (2020) pp. 213-225
Journal of Alzheimer's Disease
Journal of Alzheimer's Disease, 2020, 74 (1), pp.213-225. ⟨10.3233/JAD-190434⟩
JOURNAL OF ALZHEIMERS DISEASE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Journal of Alzheimer's Disease, 74(1), 213-225. IOS Press
Journal of Alzheimer's disease, vol. 74, no. 1, pp. 213-225
Journal of Alzheimer's disease
Journal of Alzheimer's Disease, Vol. 74, No 1 (2020) pp. 213-225
We have previously investigated, discovered, and replicated plasma protein biomarkers for use to triage potential trials participants for PET or cerebrospinal fluid measures of Alzheimer's disease (AD) pathology. This study sought to undertake valida
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee13358e04a7b6a147e71572e21e5ab6
https://research.vumc.nl/en/publications/698db593-eb1e-4e54-bfd7-40ad01166b9f
https://research.vumc.nl/en/publications/698db593-eb1e-4e54-bfd7-40ad01166b9f
Autor:
W. Maier, J. Kornhuber, L. K. Joachim, Christopher F. Bauer, Oliver Peters, Isabella Heuser, Jens Wiltfang, Lutz Frölich, E. Rüther
Publikováno v:
The journal of prevention of Alzheimer's disease 5(3), 202-206 (2018). doi:10.14283/jpad.2018.5
Background: In several randomized controlled trials (RCT) acetylcholinesterase-inhibitors (AChE-I) were tested in patients with mild cognitive impairment (MCI) but were ineffective in delaying disease progression as determined by neuropsychological t